Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	May 05, 2018	Apr. 29, 2017
Cash flows from operating activities:
Net income	$ 648,003	$ 310,693
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	113,004	83,151
Amortization of intangibles	285,004	108,717
Cost of goods sold for inventory acquired	0	121,113
Stock-based compensation expense	76,816	39,015
Deferred income taxes	(734,214)	(87,035)
Other non-cash activity	10,104	24,149
Changes in operating assets and liabilities	708,465	262,106
Total adjustments	459,179	551,216
Net cash provided by operating activities	1,107,182	861,909
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	0	(705,448)
Maturities of short-term available-for-sale investments	0	3,091,873
Sales of short-term available-for-sale investments	0	357,388
Additions to property, plant and equipment	(117,122)	(75,266)
Payments for acquisitions, net of cash acquired	(52,339)	(9,687,533)
Changes in other assets	(1,029)	(12,063)
Net cash used for investing activities	(170,490)	(7,031,049)
Cash flows from financing activities:
Proceeds from debt	743,778	11,156,164
Payments of deferred financing fees	0	(5,625)
Proceeds from derivative instruments	0	3,904
Debt repayments	(1,620,000)	0
Dividend payments to shareholders	(345,001)	(268,997)
Repurchase of common stock	(29,908)	(26,980)
Proceeds from employee stock plans	65,557	87,273
Contingent consideration payment	(542)	0
Changes in other financing activities	7,945	(16)
Net cash (used for) provided by financing activities	(1,178,171)	10,945,723
Effect of exchange rate changes on cash	158	28
Net (decrease) increase in cash and cash equivalents	(241,321)	4,776,611
Cash and cash equivalents at beginning of period	1,047,838	921,132
Cash and cash equivalents at end of period	$ 806,517	$ 5,697,743